NRNP 6675 MIDTERM EXAM (YEAR 2023 –
g g g g g g
100/100 POINTS) LATEST UPDATE 200 QUESTIONS A
g gg g g g g g
ND ANSWERS LATEST UPDATE
g g g
1. Whichgofgthegfollowinggaregriskgfactorsgforgneurolepticgmalignantgsyndrome?gSelectgallg
thatgapplyAge
Rapidgdosegescalation
Parentalgroutegofgadministration
Highergpotencygtypicalgantipsychotics
2. AntipsychoticgmedicationsgprovidegD2gblockadegingthegmesocorticalgpathwaygcausingg
whichgofgthefollowinggeffects?
Reducesgnegativegsymptoms
Increasesgextragpyramidalgsymptomsg
(EPS)Causesgprolactinemia
NRNP 6675 MIDTERM EXAM (YEAR 2022 –
g g g g g g
100/100 POINTS) LATEST UPDATE
g gg g g
,Reducesgpositivegsymptoms
3. Phencyclidineg(PCP)gandgKetaminegexertgtheirguniquegbehavioralgeffectsgbygblockingg
whichgofgthefollowinggreceptors?
GABAgtype
receptorsg
g
Serotoning
receptors
NRNP 6675 MIDTERM EXAM (YEAR 2022 –
g g g g g g
100/100 POINTS) LATEST UPDATE
g gg g g
,Dopaminegreceptors
NMDAgtypegreceptors
4. Thegdiagnosisgusedgtogdescribegagsyndromegcharacterizedgbygspecificgsignsgandgsymptom
sgresultingfromgrecentgingestiongorgexposuregtogagsubstancegisgknowngasgwhichgofgthegfollow
ing?
Substancegi
ntoxicationg
Substanceg
withdrawal
Substanceguseg
disorderAnygofgthegab
ove
5. Abnormalginvoluntarygmovementsgingagrhythmicgpatterngaffectinggface,gmouth,gtongue,gj
awgisgknownasgwhichgofgthegfollowing?
Akathisi
agDysto
g
niga
Tardivegdyskinesia
NRNP 6675 MIDTERM EXAM (YEAR 2022 –
g g g g g g
100/100 POINTS) LATEST UPDATE
g gg g g
, Extrapyramidalgsidege
ffects
6. Agdeeplygheldgbeliefgdespitegevidencegtogthegcontrary,glastinggatgleastgonegmonth,gwithoutg
prominenthallucinations,gwithgfunctionalgimpairmentgthatgrelatesgtogthegdelusionalgsyste.....
Schizophrenia
Delusionalgdisorder
g Briefgpsychoticgdis
order
Schizophreniformg disorder
NRNP 6675 MIDTERM EXAM (YEAR 2022 –
g g g g g g
100/100 POINTS) LATEST UPDATE
g gg g g
g g g g g g
100/100 POINTS) LATEST UPDATE 200 QUESTIONS A
g gg g g g g g
ND ANSWERS LATEST UPDATE
g g g
1. Whichgofgthegfollowinggaregriskgfactorsgforgneurolepticgmalignantgsyndrome?gSelectgallg
thatgapplyAge
Rapidgdosegescalation
Parentalgroutegofgadministration
Highergpotencygtypicalgantipsychotics
2. AntipsychoticgmedicationsgprovidegD2gblockadegingthegmesocorticalgpathwaygcausingg
whichgofgthefollowinggeffects?
Reducesgnegativegsymptoms
Increasesgextragpyramidalgsymptomsg
(EPS)Causesgprolactinemia
NRNP 6675 MIDTERM EXAM (YEAR 2022 –
g g g g g g
100/100 POINTS) LATEST UPDATE
g gg g g
,Reducesgpositivegsymptoms
3. Phencyclidineg(PCP)gandgKetaminegexertgtheirguniquegbehavioralgeffectsgbygblockingg
whichgofgthefollowinggreceptors?
GABAgtype
receptorsg
g
Serotoning
receptors
NRNP 6675 MIDTERM EXAM (YEAR 2022 –
g g g g g g
100/100 POINTS) LATEST UPDATE
g gg g g
,Dopaminegreceptors
NMDAgtypegreceptors
4. Thegdiagnosisgusedgtogdescribegagsyndromegcharacterizedgbygspecificgsignsgandgsymptom
sgresultingfromgrecentgingestiongorgexposuregtogagsubstancegisgknowngasgwhichgofgthegfollow
ing?
Substancegi
ntoxicationg
Substanceg
withdrawal
Substanceguseg
disorderAnygofgthegab
ove
5. Abnormalginvoluntarygmovementsgingagrhythmicgpatterngaffectinggface,gmouth,gtongue,gj
awgisgknownasgwhichgofgthegfollowing?
Akathisi
agDysto
g
niga
Tardivegdyskinesia
NRNP 6675 MIDTERM EXAM (YEAR 2022 –
g g g g g g
100/100 POINTS) LATEST UPDATE
g gg g g
, Extrapyramidalgsidege
ffects
6. Agdeeplygheldgbeliefgdespitegevidencegtogthegcontrary,glastinggatgleastgonegmonth,gwithoutg
prominenthallucinations,gwithgfunctionalgimpairmentgthatgrelatesgtogthegdelusionalgsyste.....
Schizophrenia
Delusionalgdisorder
g Briefgpsychoticgdis
order
Schizophreniformg disorder
NRNP 6675 MIDTERM EXAM (YEAR 2022 –
g g g g g g
100/100 POINTS) LATEST UPDATE
g gg g g
